Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, reduced itch and hives in patients with chronic spontaneous urticaria and showed a favorable safety profile at week 12 in two trials.
Hosted on MSN10mon
For Your Patients: What's the Best Treatment for Hives?The use of topical corticosteroids such as hydrocortisone cream is not useful for the treatment of hives, according to international clinical guidelines. Similarly, the use of systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback